Liu C, Liu W, Lu H, Fan Y, Wang A
J Inflamm Res. 2025; 18:1543-1556.
PMID: 39925939
PMC: 11806711.
DOI: 10.2147/JIR.S480911.
Wang J, Tsai P, Tseng K, Lin C, Chen F, Chang C
Antioxidants (Basel). 2025; 13(12.
PMID: 39765800
PMC: 11673382.
DOI: 10.3390/antiox13121471.
Gautam H, Shaik N, Banaganapalli B, Popowich S, Subhasinghe I, Ayalew L
J Anim Sci Biotechnol. 2024; 15(1):144.
PMID: 39487547
PMC: 11531110.
DOI: 10.1186/s40104-024-01105-5.
Giuffrida E, Platania C, Lazzara F, Conti F, Marcantonio N, Drago F
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458974
PMC: 11509888.
DOI: 10.3390/ph17101333.
Mahjabeen A, Hasan M, Rahman M, Islam M, Khan R, Kaiser M
PLoS One. 2024; 19(10):e0312072.
PMID: 39432502
PMC: 11493268.
DOI: 10.1371/journal.pone.0312072.
Fritillaria steroidal alkaloids and their multi-target therapeutic mechanisms: insights from network pharmacology.
Kumar P, Kumar V, Sharma S, Sharma R, Warghat A
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39382678
DOI: 10.1007/s00210-024-03502-z.
Crossfeat: a transformer-based cross-feature learning model for predicting drug side effect frequency.
Baek B, Lee H
BMC Bioinformatics. 2024; 25(1):324.
PMID: 39379821
PMC: 11459996.
DOI: 10.1186/s12859-024-05915-2.
Decoding the Foodome: Molecular Networks Connecting Diet and Health.
Menichetti G, Barabasi A, Loscalzo J
Annu Rev Nutr. 2024; 44(1):257-288.
PMID: 39207880
PMC: 11610447.
DOI: 10.1146/annurev-nutr-062322-030557.
Network pharmacology: an efficient but underutilized approach in oral, head and neck cancer therapy-a review.
Muthuramalingam P, Jeyasri R, Varadharajan V, Priya A, Dhanapal A, Shin H
Front Pharmacol. 2024; 15:1410942.
PMID: 39035991
PMC: 11257993.
DOI: 10.3389/fphar.2024.1410942.
Using protein turnover assay to explore the drug mechanism of Carfilzomib.
Tao Y, Ding X, Jia C, Wang C, Li C
Acta Biochim Biophys Sin (Shanghai). 2024; 57(2):209-222.
PMID: 38978505
PMC: 11877146.
DOI: 10.3724/abbs.2024104.
Hair Thickness Growth Effect of Adenosine Complex in Male-/Female-Patterned Hair Loss via Inhibition of Androgen Receptor Signaling.
Kim J, Shin J, Choi Y, Joo J, Kwack M, Sung Y
Int J Mol Sci. 2024; 25(12).
PMID: 38928239
PMC: 11204140.
DOI: 10.3390/ijms25126534.
TCM-Suite: A comprehensive and holistic platform for Traditional Chinese Medicine component identification and network pharmacology analysis.
Yang P, Lang J, Li H, Lu J, Lin H, Tian G
Imeta. 2024; 1(4):e47.
PMID: 38867910
PMC: 10989960.
DOI: 10.1002/imt2.47.
Computational drug repositioning with attention walking.
Park J, Cho Y
Sci Rep. 2024; 14(1):10072.
PMID: 38698208
PMC: 11066070.
DOI: 10.1038/s41598-024-60756-6.
A review of machine learning-based methods for predicting drug-target interactions.
Shi W, Yang H, Xie L, Yin X, Zhang Y
Health Inf Sci Syst. 2024; 12(1):30.
PMID: 38617016
PMC: 11014838.
DOI: 10.1007/s13755-024-00287-6.
GraphsformerCPI: Graph Transformer for Compound-Protein Interaction Prediction.
Zhao Z, Li T, Liu Y, Ma J, Zhang R
Interdiscip Sci. 2024; 16(2):361-377.
PMID: 38457109
DOI: 10.1007/s12539-024-00609-y.
Immunomodulatory Peptides as Vaccine Adjuvants and Antimicrobial Agents.
Hemmati S, Saeidikia Z, Seradj H, Mohagheghzadeh A
Pharmaceuticals (Basel). 2024; 17(2).
PMID: 38399416
PMC: 10892805.
DOI: 10.3390/ph17020201.
LSTM-SAGDTA: Predicting Drug-target Binding Affinity with an Attention Graph Neural Network and LSTM Approach.
Qiu W, Liang Q, Yu L, Xiao X, Qiu W, Lin W
Curr Pharm Des. 2024; 30(6):468-476.
PMID: 38323613
PMC: 11071654.
DOI: 10.2174/0113816128282837240130102817.
Calycosin ameliorates osteoarthritis by regulating the imbalance between chondrocyte synthesis and catabolism.
Su H, Yan Q, Du W, Hu E, Yang Z, Zhang W
BMC Complement Med Ther. 2024; 24(1):48.
PMID: 38254101
PMC: 10804771.
DOI: 10.1186/s12906-023-04314-z.
Deciphering the Mechanism of Xijiao Dihuang Decoction in Treating Psoriasis by Network Pharmacology and Experimental Validation.
Guo Y, Gan H, Xu S, Zeng G, Xiao L, Ding Z
Drug Des Devel Ther. 2023; 17:2805-2819.
PMID: 37719360
PMC: 10504908.
DOI: 10.2147/DDDT.S417954.
Prioritization of therapeutic targets for dyslipidemia using integrative multi-omics and multi-trait analysis.
Kim M, Song M, Kim B, Shim I, Kim D, Natarajan P
Cell Rep Med. 2023; 4(9):101112.
PMID: 37582372
PMC: 10518515.
DOI: 10.1016/j.xcrm.2023.101112.